DZHK Patient Advisory Board
Would you like to help shape the future of cardiovascular research? Then you've come to the right place! The German Center for Cardiovascular Research (DZHK) is looking for committed and motivated people who want to join the DZHK Patient Advisory Board!
What is the DZHK Patient Advisory Board?
The DZHK Patient Advisory Board intends to bring patients' and their relatives' perspectives and views into heart research. We are looking for people with different backgrounds and experiences of illness who have the time and desire to participate in cardiovascular research at the DZHK.
What exactly can you expect as a member of our Advisory Board?
You will have the opportunity to advise us on issues relating to patient communication and strategic questions and to provide feedback on how we can make studies even more patient-friendly. Together, we will try to make it easier for patients to access the studies. Your opinion counts, making research at the DZHK even more patient-friendly.
Why should you take part?
We offer you the opportunity to make a difference, add your voice, and become part of a dedicated community. You will meet new people, gain valuable experience, and actively improve the health of others.
Interested?
Then don't hesitate to apply for the DZHK Patient Advisory Board today.
Application for the DZHK Patient Advisory Board
Patient Involvement
Dr. Karin Neumann is a member of the Scientific Advisory Board of the German Centre for Cardiovascular Research and advises the DZHK on strategic and operational aspects of patient involvement in cardiovascular research. She is currently working on the establishment of a Patient Panel, which aims to make research at the DZHK even more patient-friendly. She is also involved in the Patient Participation Working Group of the German Centers for Health Research.
Karin Neumann joined the DZHK via the German Heart Foundation, where she has been a volunteer representative for several years. Due to her professional background in med-tech, among other things, she is very interested in new developments in medical research and their transfer into practice for patients.
